1. Home
  2. Companies
  3. ATX
  4. Key People

Amplia Therapeutics (ASX:ATX) - Key People

ASX:ATX · Directors, executives and key personnel · 12 month lookback

Dr Christopher J. Burns Current
Chief Executive Officer, Managing Director
Mentioned in
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Amplia Advances Narmafotinib Trials and Board with $24M Cash Position
29 July 2026
Market Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
Healthcare Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
+7 more articles →
Dr Chris Burns Current
Chief Executive Officer and Managing Director
Mentioned in
Healthcare Wrap - Week 32 (3 Aug -> 7 Aug) 2026
8 Aug 2026
Amplia Expands Narmafotinib Trials with Lilly in $31B Lung Cancer Market
4 Aug 2026
Healthcare Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
Amplia Therapeutics Advances Narmafotinib with Phase 2b Daily Dosing Trial in Pancreatic Cancer
19 May 2026
+6 more articles →

Also Mentioned

People named in Amplia Therapeutics (ASX:ATX) articles over the last 12 months, by frequency.

Robert Giordano · 8 articles Jane Bell · 6 articles Warwick Tong · 6 articles Hamish George · 5 articles Tim Lusco · 5 articles Tom Trezona · 5 articles Gwo Yaw Ho · 4 articles Robert Peach · 4 articles Haley Chartres · 3 articles Jason Lickliter · 3 articles Andrew J. Cooke · 3 articles Brett Carter · 2 articles J D Vasiliou · 1 article